; Companies & Markets: Biochip Market to Reach Nearly $10bn
Learning Center
Plans & pricing Sign in
Sign Out

Companies & Markets: Biochip Market to Reach Nearly $10bn


LONDON--(EON: Enhanced Online News)--Over 140 biochip industry participants are profiled within the global biochip market research report. a style='font-size: 10px

More Info
  • pg 1
									Companies & Markets: Biochip Market to Reach
Nearly $10bn
    l   2016 world biochip market forecast: $9.6 billion
    l   Diagnostics market segment to grow fastest, at 28.2% CAGR to 2016
    l   Five key end users examined in the report: applied markets, diagnostics, drug discovery and development;
        research tools and sequencing

October 12, 2011 07:31 AM Eastern Daylight Time 

LONDON--(EON: Enhanced Online News)--Biochip platforms are used in a diverse range of research applications
within the biotechnology sector, including pharmaceuticals, proteomics and genomics. By 2016, the biochips market
is expected to have grown to reach nearly $9.6 billion, compared with a 2010 value of $3.5 billion, representing a
CAGR of 19.5%, according to a new report available from companiesandmarkets.com.

Global Biochip Markets: Microarrays and Lab-on-a-Chip


The biochip market is experiencing rapid expansion, as scientists discover new applications for the technology as
well as developing methods of enhancing existing techniques. A key factor behind this growth has been the trend for
miniaturization, prompted by the convergence of the semiconductor and biochip industries. By embedding sensing
tools onto tiny chips the industry has created miniature laboratories (termed lab-on-a-chip) which are able to
simultaneously conduct numerous multiple biochemical tests.

Important biochip platforms, examined at length within the report include: DNA microarrays, protein microarrays,
and lab-on-a-chip. A number of specific market segments are also examined, such as digital PCR and peptide

The biochip tools segment is seeing subdued growth, as applications such as SNP genotyping and gene expression
analysis reach maturity. By 2016 this segment is expected to reach $2.7 billion, having grown at an 8.4% CAGR.
Fastest segment growth is from the biochip diagnostics segment, which will see revenues of over $4.1 billion in 2016,
compared with $1.05 billion (2010), and $2 billion (2011).

Future technology trends include array technologies such as glycomics and tissue/cell arrays.

The highly competitive market has already seen a number of strategic alliances and M&A activities. Over 140
biochip industry participants are profiled within the global biochip market research report, including: 20/20 Gene
Systems, Inc., Agendia BV, Customarray, Inc., Digital Genomics, Elim Biopharmaceuticals, Inc., Falcon Genomics,
Genalyte, Hologic, Inc., Mycroarray.Com, Oxford Gene Technology, Predictive Biosciences, Quantalife, and
Wafergen Biosystems, Inc.

The August 2011 research piece includes 376 pages of insight into the biochip, microarrays and lab-on-a-chip
market, including statistics for the period 2011-2016.

Report Details:

Companies & Markets
Mike King
Press Office
London (UK): +44 (0) 203 086 8600

Recent Stories from Companies & Markets


       Companies & Markets: Transportation Security Services Market to Hit $6 Billion
       October 12, 2011
       LONDON--(EON: Enhanced Online News)--The video surveillance technology market is the largest security
       technologies segment by revenue more »


       Companies & Markets: Healthcare Acquired Infection Control Market Set to Hit Over $30bn
       October 12, 2011
       LONDON--(EON: Enhanced Online News)--In 2016, the healthcare-acquired infection control market is
       expected to be worth in excess of $30 billion, having grown from a 2011 figure of $19 billion, at a... more »


       Companies & Markets: Microscope accessories and supplies market to grow at 5.3% CAGR to 2016
       October 12, 2011
       LONDON--(EON: Enhanced Online News)--The combined market for microscopes and accessory
       products is growing at a steady rate of around 5% CAGR, and is expected to see a 2016 valuation of at least
       $4... more »

To top